ADVERTISEMENT
Search

ADVERTISEMENT
 

Pharmacy Today logo

Researchers wield AI to address some of pharmacy’s most serious problems
Practice & Trends

On The Cover

Researchers wield AI to address some of pharmacy’s most serious problems

Artificial intelligence (AI) may have the capacity to extend its reach into virtually every industry and profession, and pharmacy is no exception. While professionals in many industries may envision ways in which the technology could make their jobs obsolete, there might be more reason for excitement than dread about the potential role for AI in pharmacy practice.

Sonya Collins

FDA approves new ER antidepressant
Drugs & Diseases

New Drug

FDA approves new ER antidepressant

In September 2023, FDA approved Exxua (gepirone), a new extendedrelease antidepressant. When Exxua comes to the market in early 2024, it will mark a new treatment option for the estimated 21 million Americans who are affected by major depressive disorder (MDD) each year.

Lauren Howell, PharmD

DHEA: The fountain of youth?
Drugs & Diseases

On The Shelf

DHEA: The fountain of youth?

DHEA supplements are advertised as an antidote to aging. Products on store shelves also purport that DHEA supports immune balance, metabolism, sexual health, mood, and bone and cardiovascular health. What is DHEA and what does it really do?

Mickie Cathers

RSS
First3334353638404142Last
ADVERTISEMENT